Colgate-Palmolive (NYSE:CL) Vice Chairman Franck J. Moison sold 30,000 shares of the company’s stock in a transaction on Friday, February 9th. The shares were sold at an average price of $69.70, for a total transaction of $2,091,000.00. Following the completion of the transaction, the insider now owns 211,048 shares in the company, valued at $14,710,045.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Colgate-Palmolive (NYSE CL) opened at $70.30 on Wednesday. The company has a market cap of $61,634.21, a PE ratio of 24.46, a PEG ratio of 2.60 and a beta of 0.75. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a fifty-two week low of $67.19 and a fifty-two week high of $77.91.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 26th. The company reported $0.75 EPS for the quarter, hitting analysts’ consensus estimates of $0.75. The firm had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.75 earnings per share. equities research analysts forecast that Colgate-Palmolive will post 3.18 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be issued a $0.40 dividend. The ex-dividend date is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 70.18%.

Several research firms have commented on CL. Citigroup upped their price objective on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Tuesday, January 30th. BNP Paribas downgraded shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Jefferies Group reiterated a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a report on Friday, January 26th. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Wednesday, November 1st. Finally, KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $77.71.

Several hedge funds have recently bought and sold shares of CL. Vanguard Group Inc. increased its stake in shares of Colgate-Palmolive by 2.4% in the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after buying an additional 1,621,392 shares during the period. BlackRock Inc. increased its position in Colgate-Palmolive by 1.4% during the 4th quarter. BlackRock Inc. now owns 52,360,691 shares of the company’s stock valued at $3,950,614,000 after purchasing an additional 711,972 shares during the period. Renaissance Technologies LLC increased its position in Colgate-Palmolive by 42.4% during the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after purchasing an additional 2,903,800 shares during the period. Geode Capital Management LLC increased its position in Colgate-Palmolive by 2.1% during the 4th quarter. Geode Capital Management LLC now owns 8,975,479 shares of the company’s stock valued at $675,751,000 after purchasing an additional 188,455 shares during the period. Finally, Arrowstreet Capital Limited Partnership increased its position in Colgate-Palmolive by 25.3% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock valued at $508,111,000 after purchasing an additional 1,385,946 shares during the period. 72.85% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2018/02/14/colgate-palmolive-cl-vice-chairman-sells-2091000-00-in-stock.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.